Erdheim-Chester Disease: Two cases from an ophthalmic perspective

Purpose: We report two patients who presented initially to ophthalmology clinics with symptoms and signs of orbital inflammation that led to a diagnosis of Erdheim-Chester Disease (ECD). Observations: ECD is a rare form of non-Langerhans cell histiocytosis (LCH) which is characterised by multi-syste...

Full description

Bibliographic Details
Main Authors: James Brodie, Sean Zhou, Damodar Makkuni, Clare Beadsmoore, Chetan Mukhtyar, Janak Saada, Kristian M. Bowles, Bijan Beigi, Ben J.L. Burton
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993620302991
_version_ 1818666397926948864
author James Brodie
Sean Zhou
Damodar Makkuni
Clare Beadsmoore
Chetan Mukhtyar
Janak Saada
Kristian M. Bowles
Bijan Beigi
Ben J.L. Burton
author_facet James Brodie
Sean Zhou
Damodar Makkuni
Clare Beadsmoore
Chetan Mukhtyar
Janak Saada
Kristian M. Bowles
Bijan Beigi
Ben J.L. Burton
author_sort James Brodie
collection DOAJ
description Purpose: We report two patients who presented initially to ophthalmology clinics with symptoms and signs of orbital inflammation that led to a diagnosis of Erdheim-Chester Disease (ECD). Observations: ECD is a rare form of non-Langerhans cell histiocytosis (LCH) which is characterised by multi-system organ involvement and poor prognosis with standard therapies. Both patients were positive for the BRAF V600E mutation on genetic testing and were treated with the BRAF inhibitors Vemurafenib and Dabrafenib respectively. These cases highlight the variable clinical presentation and course of ECD, the classical radiological and histopathological findings, and the high degree of clinical suspicion necessary to reach this diagnosis. Conclusions and importance: The combination of xanthelasma and bilateral, diffuse intraconal orbital masses must suggest to the clinician the possibility of ECD; and consideration to arrange further investigation with a full body CT or FDG PET/CT scan should be given, even in the absence of wider systemic symptoms or signs. With the advent of targeted therapies such as BRAF inhibitors, it is of even more importance that a diagnosis of ECD is established in a timely manner in order to give these patients the best chance of reduced morbidity and increased survival.
first_indexed 2024-12-17T06:03:53Z
format Article
id doaj.art-c3bee975ad644977b2984d6c2c81851d
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-12-17T06:03:53Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-c3bee975ad644977b2984d6c2c81851d2022-12-21T22:00:48ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362020-12-0120100984Erdheim-Chester Disease: Two cases from an ophthalmic perspectiveJames Brodie0Sean Zhou1Damodar Makkuni2Clare Beadsmoore3Chetan Mukhtyar4Janak Saada5Kristian M. Bowles6Bijan Beigi7Ben J.L. Burton8Department of Ophthalmology, James Paget University Hospitals NHS Trust, Great Yarmouth, Norfolk, United Kingdom; Department of Ophthalmology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United Kingdom; Corresponding author. Sidestrand, Wherry Road, Norwich, NR1 1TB, United Kingdom.Department of Ophthalmology, James Paget University Hospitals NHS Trust, Great Yarmouth, Norfolk, United KingdomDepartment of Rheumatology, James Paget University Hospitals NHS Trust, Great Yarmouth, Norfolk, United KingdomDepartment of Radiology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United KingdomDepartment of Rheumatology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United KingdomDepartment of Radiology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United KingdomDepartment of Medicine – Haematology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United KingdomDepartment of Ophthalmology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, United KingdomDepartment of Ophthalmology, James Paget University Hospitals NHS Trust, Great Yarmouth, Norfolk, United KingdomPurpose: We report two patients who presented initially to ophthalmology clinics with symptoms and signs of orbital inflammation that led to a diagnosis of Erdheim-Chester Disease (ECD). Observations: ECD is a rare form of non-Langerhans cell histiocytosis (LCH) which is characterised by multi-system organ involvement and poor prognosis with standard therapies. Both patients were positive for the BRAF V600E mutation on genetic testing and were treated with the BRAF inhibitors Vemurafenib and Dabrafenib respectively. These cases highlight the variable clinical presentation and course of ECD, the classical radiological and histopathological findings, and the high degree of clinical suspicion necessary to reach this diagnosis. Conclusions and importance: The combination of xanthelasma and bilateral, diffuse intraconal orbital masses must suggest to the clinician the possibility of ECD; and consideration to arrange further investigation with a full body CT or FDG PET/CT scan should be given, even in the absence of wider systemic symptoms or signs. With the advent of targeted therapies such as BRAF inhibitors, it is of even more importance that a diagnosis of ECD is established in a timely manner in order to give these patients the best chance of reduced morbidity and increased survival.http://www.sciencedirect.com/science/article/pii/S2451993620302991HistiocytosisErdheim-chester diseaseVemurafenibBRAFOrbital massOrbital inflammation
spellingShingle James Brodie
Sean Zhou
Damodar Makkuni
Clare Beadsmoore
Chetan Mukhtyar
Janak Saada
Kristian M. Bowles
Bijan Beigi
Ben J.L. Burton
Erdheim-Chester Disease: Two cases from an ophthalmic perspective
American Journal of Ophthalmology Case Reports
Histiocytosis
Erdheim-chester disease
Vemurafenib
BRAF
Orbital mass
Orbital inflammation
title Erdheim-Chester Disease: Two cases from an ophthalmic perspective
title_full Erdheim-Chester Disease: Two cases from an ophthalmic perspective
title_fullStr Erdheim-Chester Disease: Two cases from an ophthalmic perspective
title_full_unstemmed Erdheim-Chester Disease: Two cases from an ophthalmic perspective
title_short Erdheim-Chester Disease: Two cases from an ophthalmic perspective
title_sort erdheim chester disease two cases from an ophthalmic perspective
topic Histiocytosis
Erdheim-chester disease
Vemurafenib
BRAF
Orbital mass
Orbital inflammation
url http://www.sciencedirect.com/science/article/pii/S2451993620302991
work_keys_str_mv AT jamesbrodie erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT seanzhou erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT damodarmakkuni erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT clarebeadsmoore erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT chetanmukhtyar erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT janaksaada erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT kristianmbowles erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT bijanbeigi erdheimchesterdiseasetwocasesfromanophthalmicperspective
AT benjlburton erdheimchesterdiseasetwocasesfromanophthalmicperspective